News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Singulex, Inc. Announces Issuance of U.S. Patents for Single Molecule Detection of Protein Biomarkers and Key Biomarker for Cardiac Risk Monitoring


12/14/2010 9:34:05 AM

ALAMEDA, Calif.--(BUSINESS WIRE)--Singulex, Inc., the leader in high-definition immunodiagnostic technology, announced today that the U.S. Patent & Trademark Office has issued two patents related to the Company’s Erenna® Technology, for the quantitative measurement of single molecules in complex biological samples. The patented technology enables the Erenna Immunoassay System to integrate single molecule counting into microparticle-based immunoassays that dramatically improve assay sensitivity.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES